Pain and quality of life of children and adolescents with osteogenesis imperfecta over a bisphosphonate treatment cycle
- 11 April 2018
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 177 (6) , 891-902
Abstract
The objective was to describe the pain and quality of life among children and adolescents with any osteogenesis imperfecta (OI) type over one intravenous bisphosphonate treatment cycle from a child and parental perspective. A prospective, observational study was conducted, where children and adolescents evaluated their pain intensity, location, and quality, as well as quality of life before, 1 week after treatment, and 6 months later. Quality of life was also evaluated from the parental perspective at the same three time points. Thirty-three child/parent dyads participated. The results showed that pain intensity on the 0–10 self-report scale after the Zoledronate infusion (median = 0, range = 0–6) was not different from pre (median = 2, range = 0–10) and 6-months post-scores (median = 2, range = 0–8) (p = 0.170). Children and adolescents with OI reported experiencing pain mainly in the ankles and the anterior and posterior shoulders. They selected evaluative pain descriptors such as uncomfortable (n = 16, 48%) and annoying (n = 13, 39%). Children and adolescents’ functioning and quality of life did not change significantly across the bisphosphonate treatment cycle (p = 0.326), parents perceived an improvement immediately after the treatment compared to before (p = 0.016).Keywords
Funding Information
- Québec Network on Nursing Intervention Research
- Newton Foundation
- Scotiabank
- Tunis Temple
This publication has 43 references indexed in Scilit:
- Development and Testing of a Multidimensional iPhone Pain Assessment Application for Adolescents with CancerJournal of Medical Internet Research, 2013
- A Quantitative Review of Ethnic Group Differences in Experimental Pain Response: Do Biology, Psychology, and Culture Matter?Pain Medicine, 2012
- A randomized, controlled dose-ranging study of risedronate in children with moderate and severe osteogenesis imperfectaJournal of Bone and Mineral Research, 2010
- Parents of children and adolescents with chronic painPain, 2009
- Propriétés psychométriques du questionnaire générique français « Pediatric Quality of Life Inventory Version 4.0» (PedsQLTM 4.0)European Review of Applied Psychology, 2009
- Risedronate in the Treatment of Mild Pediatric Osteogenesis Imperfecta: A Randomized Placebo-Controlled StudyJournal of Bone and Mineral Research, 2009
- Effects of Oral Alendronate on BMD in Adult Patients With Osteogenesis Imperfecta: A 3-Year Randomized Placebo-Controlled TrialJournal of Bone and Mineral Research, 2006
- Parent and family factors in pediatric chronic pain and disability: An integrative approachPain, 2005
- Fracture and non‐fracture pain in children with osteogenesis imperfectaActa Paediatrica, 2005
- Self-assessment of immediate post-vaccination pain after two different MMR vaccines administered as a second dose in 4- to 6-year-old childrenVaccine, 2004